Nonresponders of interferon/ribavirin treatment for recurrent hepatitis C following liver transplantation

By Smallwood G.A.   Davis L.   Connor K.   Martinez E.   Stieber A.C.   Heffron T.G.  

Transplantation Proceedings, Vol. 35, Iss. 4, 2003-06 ,pp. : 1476-1477

Elsevier

Access to resources Recommend Favorite

The hepatitis C virus NS5A protein and response to interferon α: mutational analyses in patients with chronic HCV genotype 3a infection from India

By Goyal Ankur   Hofmann Wolf   Hermann Eva   Traver Stella   Hissar Syed   Arora Naveen   Blum Hubert   Zeuzem Stefan   Sarrazin Christoph   Sarin Shiv  

Medical Microbiology and Immunology, Vol. 196, Iss. 1, 2007-03 ,pp. : 11-21

Springer Publishing Company

Access to resources Recommend Favorite

Combination of interferon- and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation

By Ben-Ari Z.   Mor E.   Shaharabani E.   Bar-Nathan N.   Shapira Z.   Tur-Kaspa R.  

Transplantation Proceedings, Vol. 32, Iss. 4, 2000-06 ,pp. : 714-716

Elsevier

Access to resources Recommend Favorite

Daily interferon Alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection

By Beckebaum S.   Cicinnati V.R.   Karliova M.   Dirsch O.   Erim Y.   Frilling A.   Malago M.   Broelsch C.E.   Treichel U.   Gerken G.  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2080-2081

Elsevier

Access to resources Recommend Favorite

Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin

By Campos-de-Magalhães Marilza   Eduardo Brandão-Mello Carlos   Lúcia Elias Pires Maria   Cecília da Fonseca Salgado Maria   Barcelo de Brito Selma   José de Almeida Adilson  

Hematology, Vol. 16, Iss. 2, 2011-03 ,pp. : 80-85

Maney Publishing

Access to resources Recommend Favorite